PIERUCCI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 208
EU - Europa 144
AS - Asia 93
SA - Sud America 1
Totale 446
Nazione #
US - Stati Uniti d'America 207
IT - Italia 56
IE - Irlanda 51
SG - Singapore 43
HK - Hong Kong 32
CN - Cina 9
FR - Francia 8
KR - Corea 8
DE - Germania 7
UA - Ucraina 6
FI - Finlandia 5
AT - Austria 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
RU - Federazione Russa 2
SE - Svezia 2
CO - Colombia 1
CR - Costa Rica 1
LV - Lettonia 1
UZ - Uzbekistan 1
Totale 446
Città #
Dublin 51
Chandler 39
Singapore 37
Hong Kong 32
Boardman 20
Perugia 20
Redmond 14
Santa Clara 14
San Mateo 9
Altamura 8
Bastia umbra 8
Seoul 8
Lawrence 5
Medford 5
Princeton 5
Wilmington 5
Andover 4
Jacksonville 4
New York 4
Paris 4
Florence 3
Helsinki 3
Los Angeles 3
Ashburn 2
Falkenstein 2
Milan 2
Munich 2
Padova 2
Sinalunga 2
Tappahannock 2
West Jordan 2
Anguillara Sabazia 1
Apo 1
Bari 1
Beijing 1
Bogotá 1
Cambridge 1
Clifton 1
Dallas 1
Edinburgh 1
Houston 1
Lappeenranta 1
Moscow 1
Nagold 1
Olomouc 1
Prague 1
Riga 1
Rome 1
San José 1
Stockholm 1
Vienna 1
Woodbridge 1
Totale 342
Nome #
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 63
Tipranavir exhibits different effects on opportunistic pathogenic fungi. 54
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 53
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 47
Seroprevalence of anti-SARS-CoV2 antibodies in umbrian persons living with HIV 45
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 45
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 30
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 26
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 24
Nelfinavir: An Old Ally in the COVID-19 Fight? 22
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 20
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 15
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 14
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 13
Totale 471
Categoria #
all - tutte 3.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 1 0 1 0 0 0
2020/202140 0 1 0 1 3 0 1 2 1 14 1 16
2021/202249 2 10 1 2 1 2 0 10 1 3 12 5
2022/2023166 5 20 2 25 15 12 1 11 68 0 7 0
2023/2024100 6 10 3 0 1 2 32 1 14 8 12 11
2024/2025103 10 22 5 23 21 22 0 0 0 0 0 0
Totale 471